Skip to main content
Premium Trial:

Request an Annual Quote

Center for Human Genetics to Cease Offering Athena Dx's Tests

NEW YORK (GenomeWeb News) – The Center for Human Genetics of Boston University and the Center for Human Genetics Inc., will stop offering testing services that are covered by patents licensed to Athena Diagnostics, Boston University said today.
Athena Diagnostics, a subsidiary of Thermo Fisher Scientific, focuses on offering tests for neurological diseases, such as Alzheimer’s disease and neuromuscular diseases, that it licenses from universities.
The tests CHG has agreed to stop offering include those for hearing loss related to A1555G or Connexin 26 mutations, developmental disorders; myotonic dystrophy; Friedreich’s Ataxia; hereditary neuropathy; polycystic kidney disease; spinal muscular atrophy; spinocerebellar ataxia; and tuberous sclerosis.
The University said the agreement followed a negotiated settlement with the company. It added that the settlement does not affect any non-commercial research activities at BU.
BU said that CHG has advised its customers that it will forward requests for Athena-licensed tests to the company for processing, or it will notify clients that they may take requests to Athena directly.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.